1. Home
  2. IMCR vs GAM Comparison

IMCR vs GAM Comparison

Compare IMCR & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

N/A

Current Price

$26.33

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo General American Investors Inc.

GAM

General American Investors Inc.

N/A

Current Price

$53.23

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMCR
GAM
Founded
2008
1927
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
IMCR
GAM
Price
$26.33
$53.23
Analyst Decision
Buy
Analyst Count
12
0
Target Price
★ $59.30
N/A
AVG Volume (30 Days)
★ 414.0K
28.8K
Earning Date
11-06-2026
01-01-0001
Dividend Yield
N/A
★ 5.74%
EPS Growth
★ 30.39
N/A
EPS
N/A
★ 11.67
Revenue
★ $249,428,000.00
N/A
Revenue This Year
$9.28
N/A
Revenue Next Year
$9.91
N/A
P/E Ratio
★ N/A
$4.68
Revenue Growth
★ 43.05
N/A
52 Week Low
$26.53
$54.41
52 Week High
$40.71
$68.57

Technical Indicators

Market Signals
Indicator
IMCR
GAM
Relative Strength Index (RSI) 32.57 21.94
Support Level N/A N/A
Resistance Level $31.75 $65.31
Average True Range (ATR) 1.46 1.58
MACD -0.46 -1.18
Stochastic Oscillator 9.12 2.85

Price Performance

Historical Comparison
IMCR
GAM

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About GAM General American Investors Inc.

General American Investors Co Inc is a closed-end, diversified management investment company. It manages a portfolio of investments, consisting of common stocks of U.S. companies, as well as international and private securities.

Share on Social Networks: